Deltex Medical Group (LON:DEMG) has added a third West Coast teaching hospital to the growing list of US users of its blood monitoring systems.
Deltex said the hospital, which was not named, had been buying its ODM systems and probes for five years, but had now made this into a formal agreement for up to 100 probes per month.
The package will include new monitors, e-learning and simulation packages and a tailored dedicated training programme.
It is the third 'platform programme' account on the US West Coast, the company's longest established US sales region and takes the number of US platform programme accounts to 13.
Earlier this month, the hospital also became the first in the US to order paediatric probes.
Ewan Phillips, Deltex Medical's chief executive, said this was the seventh new account for its US platform programme this year and the 13th in total.
“The US continues to be an increasingly important market for us and we see it becoming our key territory.
“We are making good progress towards our current goal of 30 US hospitals on our platform programme by mid-2016.”